200 Participants Needed

Prospective Analysis for Extradural Abscess

(SEA Trial)

JH
HA
Francis Farhadi, MD, PhD profile photo
Overseen ByFrancis Farhadi, MD, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Francis Farhadi
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to gather detailed information on patients with spinal epidural abscess, a serious infection around the spinal cord. Researchers seek to understand how factors like a history of drug abuse affect the condition and treatment outcomes by reviewing patient records over a year. The study divides participants into two groups: those with a history of drug abuse and those without. It suits individuals diagnosed with spinal infections who are willing to attend follow-up appointments. As an unphased trial, this study offers patients the opportunity to contribute to a deeper understanding of spinal infections and their treatment.

Do I need to stop my current medications for the trial?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Why are researchers excited about this trial?

Researchers are excited about this trial because it aims to shed light on the differences in outcomes for patients with spinal epidural abscesses based on their history of drug abuse. Unlike traditional studies focusing on specific treatments, this trial uses a prospective chart review to gather detailed data and provide insights into how past drug abuse might affect the progression and management of spinal epidural abscesses. Understanding these differences could lead to more personalized and effective care strategies for this condition in the future.

Who Is on the Research Team?

FF

Francis Farhadi, MD, PhD

Principal Investigator

University of Kentucky

Are You a Good Fit for This Trial?

Inclusion Criteria

All patient with ICD codes for pyogenic vertebral osteomyelitis, discitis, and spinal epidural abscess will be reviewed for inclusion.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Data Collection

Collection of clinical, pathological, radiological, and socioeconomic data of patients diagnosed with spinal epidural abscess

2 years

Follow-up

Participants are monitored for infection reoccurrence and correlation with socioeconomic factors

1 year

What Are the Treatments Tested in This Trial?

Interventions

  • Prospective chart review of subjects diagnosed with spinal epidural abscess

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Group I: Subjects with spinal epidural abscess with no history of drug abuseExperimental Treatment1 Intervention
Group II: Subjects with spinal epidural abscess with a history of drug abuseExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Francis Farhadi

Lead Sponsor

Trials
2
Recruited
330+

University of Kentucky

Lead Sponsor

Trials
198
Recruited
224,000+